{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:56:36Z","timestamp":1791428196731,"version":"4.3.3"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.eclinm.2022.101368","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T20:26:53Z","timestamp":1649276813000},"page":"101368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Imogen","family":"Cowdell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Portwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-3999","authenticated-orcid":false,"given":"Harriet","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kumarendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Kirtley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-7457","authenticated-orcid":false,"given":"Joris","family":"Hemelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2022.101368_bib0001","unstructured":"UNAIDS. Global AIDS update 2021. 2021."},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0002","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"issue":"10053","key":"10.1016\/j.eclinm.2022.101368_bib0003","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(16)31575-6","article-title":"Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"issue":"10063","key":"10.1016\/j.eclinm.2022.101368_bib0004","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101368_bib0005","doi-asserted-by":"crossref","first-page":"j3677","DOI":"10.1136\/bmj.j3677","article-title":"Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets","volume":"358","author":"Lee","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0006","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2214-109X(13)70006-8","article-title":"National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Glob Health"},{"issue":"10303","key":"10.1016\/j.eclinm.2022.101368_bib0007","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(21)01207-1","article-title":"Global, regional, and national progress towards sustainable development goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101368_bib0008","series-title":"Recommendations for a Public Health Approach","article-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","year":"2013"},{"key":"10.1016\/j.eclinm.2022.101368_bib0009","unstructured":"UNAIDS. UNAIDS data. 2020."},{"key":"10.1016\/j.eclinm.2022.101368_bib0010","series-title":"Recommendations for a Public Health Approach","article-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","year":"2016"},{"key":"10.1016\/j.eclinm.2022.101368_bib0011","unstructured":"UNAIDS. Start Free, Stay Free, AIDS Free. 2019."},{"key":"10.1016\/j.eclinm.2022.101368_bib0012","unstructured":"WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021."},{"key":"10.1016\/j.eclinm.2022.101368_bib0013","unstructured":"Panel on treatment of pregnant women with HIV infection and prevention of perinatal transmission - A Working Group of the Office of AIDS Research Advisory Council (OARAC). Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States, 2021."},{"key":"10.1016\/j.eclinm.2022.101368_bib0014","unstructured":"European AIDS Clinical Society. Treatment of pregnant women living with HIV or women considering pregnancy. EACS Guidelines 2021; v11."},{"key":"10.1016\/j.eclinm.2022.101368_bib0015","unstructured":"BHIVA. British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018 (2020 third interim update). 2020."},{"issue":"11","key":"10.1016\/j.eclinm.2022.101368_bib0016","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/QAD.0000000000002593","article-title":"Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis","volume":"34","author":"Tshivuila-Matala","year":"2020","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101368_bib0017","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"Powis","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101368_bib0018","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAD.0000000000002039","article-title":"European pregnancy and paediatric HIV cohort collaboration (EPPICC) study group. Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes","volume":"33","author":"Bailey","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2022.101368_bib0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2393-12-93","article-title":"Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women","volume":"12","author":"Ezechi","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101368_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0000000000001694","article-title":"Protease inhibitors and preterm delivery: another piece in the puzzle","volume":"32","author":"Favarato","year":"2018","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101368_bib0021","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s15010-019-01384-5","article-title":"Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study","volume":"48","author":"Floridia","year":"2020","journal-title":"Infection"},{"issue":"24","key":"10.1016\/j.eclinm.2022.101368_bib0022","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana","volume":"362","author":"Shapiro","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101368_bib0023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/hiv.12083","article-title":"Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission","volume":"15","author":"Short","year":"2014","journal-title":"HIV Med"},{"issue":"18","key":"10.1016\/j.eclinm.2022.101368_bib0024","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/01.aids.0000253362.01696.9d","article-title":"Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth","volume":"20","author":"Szyld","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2022.101368_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1758-2652-14-42","article-title":"Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study","volume":"14","author":"van der Merwe","year":"2011","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101368_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.eclinm.2022.101368_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/135030","article-title":"Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy","volume":"2012","author":"Aaron","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101368_bib0028","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/QAD.0000000000002464","article-title":"Investigation of factors associated with spontaneous preterm birth in pregnant women living with HIV","volume":"34","author":"Albert","year":"2020","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101368_bib0029","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.2006.01183.x","article-title":"The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery","volume":"114","author":"Boer","year":"2007","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101368_bib0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1592\/phco.29.11.1289","article-title":"Lack of effect on prematurity, birth weight, and infant growth from exposure to protease inhibitors in utero and after birth","volume":"29","author":"Carceller","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101368_bib0031","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana","volume":"206","author":"Chen","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0032","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12978-018-0513-8","article-title":"Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study","volume":"15","author":"Delicio","year":"2018","journal-title":"Reprod Health"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101368_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027344","article-title":"Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study","volume":"9","author":"Ejigu","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAI.0000000000002087","article-title":"Stillbirth in women living with HIV delivering in the United Kingdom and Ireland: 2007\u20132015","volume":"82","author":"Favarato","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4 Pt 1","key":"10.1016\/j.eclinm.2022.101368_bib0035","first-page":"459","article-title":"Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women","volume":"7","author":"Kowalska","year":"2003","journal-title":"Med Wieku Rozwoj"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101368_bib0036","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10096-014-2224-6","article-title":"Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study","volume":"34","author":"L\u00f3pez","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101368_bib0037","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/sti.2008.032300","article-title":"Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception","volume":"85","author":"Machado","year":"2009","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0038","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijgo.2015.02.019","article-title":"Management and outcomes of pregnancies among women with HIV in Oxford, UK, in 2008\u20132012","volume":"130","author":"Montgomery-Taylor","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101368_bib0039","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1542\/peds.2006-1123","article-title":"Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989\u20132004","volume":"119","author":"Schulte","year":"2007","journal-title":"Pediatrics"},{"issue":"1s","key":"10.1016\/j.eclinm.2022.101368_bib0040","first-page":"359s","article-title":"Comparison of four classical PI- and raltegravir-based regimens during pregnancy","volume":"26","author":"Sibiude","year":"2018","journal-title":"Top Antivir Med"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191389","article-title":"Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age","volume":"13","author":"Snijdewind","year":"2018","journal-title":"PLoS One"},{"issue":"03","key":"10.1016\/j.eclinm.2022.101368_bib0042","first-page":"172","article-title":"Do protease inhibitors increase preterm births in human immunodeficiency virus-infected patients?","volume":"03","author":"Williams","year":"2013","journal-title":"Adv Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101368_bib0043","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/infdis\/jis728","article-title":"Combination antiretroviral use and preterm birth","volume":"207","author":"Watts","year":"2013","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101368_bib0044","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2022.101368_bib0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12978-016-0149-5","article-title":"Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis","volume":"13","author":"Mesfin","year":"2016","journal-title":"Reprod Health"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101368_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198447","article-title":"Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: systematic review and network meta-analysis including different study designs","volume":"13","author":"Veroniki","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000001770","article-title":"Use of antiretroviral therapy during pregnancy and adverse birth outcomes among women living with HIV-1 in low- and middle-income countries: a systematic review","volume":"79","author":"Saleska","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0048","first-page":"31","article-title":"Antiretroviral therapy and pregnancy outcomes in developing countries: a systematic review","volume":"3","author":"Alemu","year":"2015","journal-title":"Int J MCH AIDS"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0049","first-page":"38","article-title":"Safety and efficacy of lopinavir\/ritonavir during pregnancy: a systematic review","volume":"15","author":"Pasley","year":"2013","journal-title":"AIDS Rev"},{"key":"10.1016\/j.eclinm.2022.101368_bib0050","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1038\/srep08528","article-title":"Efficacy and biological safety of lopinavir\/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials","volume":"5","author":"Huang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2022.101368_bib0051","series-title":"Cochrane Handbook For Systematic Reviews of Interventions","article-title":"Cochrane Handbook For Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1016\/j.eclinm.2022.101368_bib0052","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101368_bib0053","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/jac\/dkt497","article-title":"Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study","volume":"69","author":"Floridia","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101368_bib0054","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jac\/dkx478","article-title":"Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study","volume":"73","author":"Floridia","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eclinm.2022.101368_bib0055","doi-asserted-by":"crossref","first-page":"19933","DOI":"10.7448\/IAS.18.1.19933","article-title":"Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?","volume":"18","author":"Kakkar","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0056","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/hiv.12277","article-title":"Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates","volume":"17","author":"Perry","year":"2016","journal-title":"HIV Med."},{"issue":"17","key":"10.1016\/j.eclinm.2022.101368_bib0057","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMoa1701666","article-title":"Birth outcomes for pregnant women with HIV using Tenofovir-Emtricitabine","volume":"378","author":"Rough","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101368_bib0058","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/cid\/cis198","article-title":"Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?","volume":"54","author":"Sibiude","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101368_bib0059","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9848041","article-title":"Maternal Lopinavir\/ritonavir is associated with fewer adverse events in infants than Nelfinavir or Atazanavir","volume":"2016","author":"Smith","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101368_bib0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0b013e328133884b","article-title":"Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland","volume":"21","author":"Townsend","year":"2007","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101368_bib0061","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/AOG.0000000000002046","article-title":"Committee opinion No 700: methods for estimating the due date","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"9946","key":"10.1016\/j.eclinm.2022.101368_bib0062","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(14)61490-2","article-title":"International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project","volume":"384","author":"Papageorghiou","year":"2014","journal-title":"Lancet"},{"issue":"9946","key":"10.1016\/j.eclinm.2022.101368_bib0063","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st Project","volume":"384","author":"Villar","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0064","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101368_bib0065","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/S2352-3018(17)30046-2","article-title":"Preconception ART and preterm birth: real effect or selection bias?","volume":"4","author":"Stringer","year":"2017","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0066","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0067","first-page":"13265","article-title":"Innate Lymphoid cells are reduced in pregnant HIV positive women and are associated with preterm birth","volume":"10","author":"Akoto","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101368_bib0068","doi-asserted-by":"crossref","first-page":"e13240","DOI":"10.1111\/aji.13240","article-title":"Changes in the V\u03b17.2+ CD161++ MAIT cell compartment in early pregnancy are associated with preterm birth in HIV-positive women","volume":"83","author":"Ravi","year":"2020","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101368_bib0069","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1086\/511983","article-title":"Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy","volume":"195","author":"Fiore","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0070","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1038\/s41598-021-89551-3","article-title":"Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women","volume":"11","author":"Akoto","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101368_bib0071","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/S2352-3018(21)00249-6","article-title":"Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua","volume":"2","author":"Dunk","year":"2021","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101368_bib0072","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/infdis\/jiw004","article-title":"Low prolactin and high 20-alpha-hydroxysteroid dehydrogenase levels contribute to lower progesterone levels in HIV-infected pregnant women exposed to protease inhibitor-based combination antiretroviral therapy","volume":"213","author":"Papp","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101368_bib0073","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiu393","article-title":"HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction","volume":"211","author":"Papp","year":"2015","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101368_bib0074","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1016\/S2352-3018(21)00150-8","article-title":"Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"Price","year":"2021","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101368_bib0075","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/QAD.0000000000002222","article-title":"Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa","volume":"33","author":"Santosa","year":"2019","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101368_bib0076","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana","volume":"381","author":"Zash","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101368_bib0077","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","article-title":"Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study","volume":"6","author":"Zash","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"10281","key":"10.1016\/j.eclinm.2022.101368_bib0078","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(21)00314-7","volume":"397","author":"Lockman","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101368_bib0079","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2352-3018(20)30050-3","article-title":"Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial","volume":"7","author":"Kintu","year":"2020","journal-title":"Lancet HIV"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:11:07Z","timestamp":1762888267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":79,"alternative-id":["S2589537022000980"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101368","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101368"}}